Brii Biosciences Ltd
HKEX:2137

Watchlist Manager
Brii Biosciences Ltd Logo
Brii Biosciences Ltd
HKEX:2137
Watchlist
Price: 1.47 HKD -2% Market Closed
Market Cap: 1.1B HKD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of Brii Biosciences Ltd.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
Not Available
Base Case Scenario
Compare Brii Biosciences Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Brii Biosciences Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Brii Biosciences Ltd

Current Assets 2.1B
Cash & Short-Term Investments 2.1B
Other Current Assets 14.4m
Non-Current Assets 396.1m
Long-Term Investments 7m
PP&E 11.3m
Intangibles 303.5m
Other Non-Current Assets 74.3m
Current Liabilities 48.6m
Accrued Liabilities 17.1m
Other Current Liabilities 31.5m
Non-Current Liabilities -48.8m
Long-Term Debt 2.9m
Other Non-Current Liabilities -51.7m
Efficiency

Free Cash Flow Analysis
Brii Biosciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Brii Biosciences Ltd

Revenue
0 CNY
Operating Expenses
-339.5m CNY
Operating Income
-339.5m CNY
Other Expenses
-36.2m CNY
Net Income
-375.7m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Brii Biosciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Positive 3Y Average ROE
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
hidden
Profitability
Score

Brii Biosciences Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Brii Biosciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Brii Biosciences Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Brii Biosciences Ltd

Wall Street analysts forecast Brii Biosciences Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Brii Biosciences Ltd is 2.04 HKD with a low forecast of 2.02 HKD and a high forecast of 2.1 HKD.

Lowest
Price Target
2.02 HKD
37% Upside
Average
Price Target
2.04 HKD
39% Upside
Highest
Price Target
2.1 HKD
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Brii Biosciences Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Brii Biosciences Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y